Table 2. Association of HR HPV genotypes with markers of cancer progression.
|
Statistical analysis |
||||||
|---|---|---|---|---|---|---|
| HR HPV genotype | Risk marker | Grade | No. of cancers positive/total | 2P | OR | 95% CI |
| 16 | Origin | Squamous | 37/51 | 0.022 | 3.000 | 1.074–8.388 |
| Differentiation | Moderate | 31/51 | 0.025 | 2.959 | 1.076–8.292 | |
| Vessel involvement | 32/51 | 0.003 | 4.304 | 1.508–12.689 | ||
| Group A (16+aothers) | Differentiation | Moderate | 36/63 | 0.042 | 3.111 | 0.954–11.081 |
| 18 | Origin | Adenocarcinoma | 8/14 | <0.001 | 10.167 | 2.316–44.760 |
Only significant associations are shown.
a
Other types detected were HPV31, 33, 52 and 58, all of which are members of HPV Group A. HPV18 is classified in Group C.